These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12601549)

  • 1. Hypermethylation associated with inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human hepatoblastomas.
    Nagai H; Naka T; Terada Y; Komazaki T; Yabe A; Jin E; Kawanami O; Kishimoto T; Konishi N; Nakamura M; Kobayashi Y; Emi M
    J Hum Genet; 2003; 48(2):65-9. PubMed ID: 12601549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermethylation-associated inactivation of the SOCS-1 gene, a JAK/STAT inhibitor, in human pancreatic cancers.
    Komazaki T; Nagai H; Emi M; Terada Y; Yabe A; Jin E; Kawanami O; Konishi N; Moriyama Y; Naka T; Kishimoto T
    Jpn J Clin Oncol; 2004 Apr; 34(4):191-4. PubMed ID: 15121754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined hypermethylation and chromosome loss associated with inactivation of SSI-1/SOCS-1/JAB gene in human hepatocellular carcinomas.
    Nagai H; Kim YS; Konishi N; Baba M; Kubota T; Yoshimura A; Emi M
    Cancer Lett; 2002 Dec; 186(1):59-65. PubMed ID: 12183076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity.
    Yoshikawa H; Matsubara K; Qian GS; Jackson P; Groopman JD; Manning JE; Harris CC; Herman JG
    Nat Genet; 2001 May; 28(1):29-35. PubMed ID: 11326271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma.
    Galm O; Yoshikawa H; Esteller M; Osieka R; Herman JG
    Blood; 2003 Apr; 101(7):2784-8. PubMed ID: 12456503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Constitutional activation of IL-6-mediated JAK/STAT pathway through hypermethylation of SOCS-1 in human gastric cancer cell line.
    To KF; Chan MW; Leung WK; Ng EK; Yu J; Bai AH; Lo AW; Chu SH; Tong JH; Lo KW; Sung JJ; Chan FK
    Br J Cancer; 2004 Oct; 91(7):1335-41. PubMed ID: 15354212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma.
    Niwa Y; Kanda H; Shikauchi Y; Saiura A; Matsubara K; Kitagawa T; Yamamoto J; Kubo T; Yoshikawa H
    Oncogene; 2005 Sep; 24(42):6406-17. PubMed ID: 16007195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis.
    Okochi O; Hibi K; Sakai M; Inoue S; Takeda S; Kaneko T; Nakao A
    Clin Cancer Res; 2003 Nov; 9(14):5295-8. PubMed ID: 14614012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypermethylation of the p16 gene and lack of p16 expression in hepatoblastoma.
    Shim YH; Park HJ; Choi MS; Kim JS; Kim H; Kim JJ; Jang JJ; Yu E
    Mod Pathol; 2003 May; 16(5):430-6. PubMed ID: 12748249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of SSI-1, a JAK/STAT inhibitor, in human hepatocellular carcinomas, as revealed by two-dimensional electrophoresis.
    Nagai H; Kim YS; Lee KT; Chu MY; Konishi N; Fujimoto J; Baba M; Matsubara K; Emi M
    J Hepatol; 2001 Mar; 34(3):416-21. PubMed ID: 11322203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic inactivation of SOCS-1 by CpG island hypermethylation in human gastric carcinoma.
    Oshimo Y; Kuraoka K; Nakayama H; Kitadai Y; Yoshida K; Chayama K; Yasui W
    Int J Cancer; 2004 Dec; 112(6):1003-9. PubMed ID: 15386345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma.
    Miyoshi H; Fujie H; Moriya K; Shintani Y; Tsutsumi T; Makuuchi M; Kimura S; Koike K
    J Gastroenterol; 2004 Jun; 39(6):563-9. PubMed ID: 15235874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential hypermethylation of SOCS genes in ovarian and breast carcinomas.
    Sutherland KD; Lindeman GJ; Choong DY; Wittlin S; Brentzell L; Phillips W; Campbell IG; Visvader JE
    Oncogene; 2004 Oct; 23(46):7726-33. PubMed ID: 15361843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C virus core protein exerts an inhibitory effect on suppressor of cytokine signaling (SOCS)-1 gene expression.
    Miyoshi H; Fujie H; Shintani Y; Tsutsumi T; Shinzawa S; Makuuchi M; Kokudo N; Matsuura Y; Suzuki T; Miyamura T; Moriya K; Koike K
    J Hepatol; 2005 Nov; 43(5):757-63. PubMed ID: 16083990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated expression of Wnt antagonists is a common event in hepatoblastomas.
    Koch A; Waha A; Hartmann W; Hrychyk A; Schüller U; Waha A; Wharton KA; Fuchs SY; von Schweinitz D; Pietsch T
    Clin Cancer Res; 2005 Jun; 11(12):4295-304. PubMed ID: 15958610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC.
    Calvisi DF; Ladu S; Gorden A; Farina M; Conner EA; Lee JS; Factor VM; Thorgeirsson SS
    Gastroenterology; 2006 Apr; 130(4):1117-28. PubMed ID: 16618406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOCS proteins: negative regulators of cytokine signaling.
    Krebs DL; Hilton DJ
    Stem Cells; 2001; 19(5):378-87. PubMed ID: 11553846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatoblastomas exhibit marked
    Rivas MP; Aguiar TFM; Maschietto M; Lemes RB; Caires-Júnior LC; Goulart E; Telles-Silva KA; Novak E; Cristofani LM; Odone V; Cypriano M; de Toledo SRC; Carraro DM; Escobar MQ; Lee H; Johnston M; da Costa CML; da Cunha IW; Tasic L; Pearson PL; Rosenberg C; Timchenko N; Krepischi ACV
    Tumour Biol; 2020 Dec; 42(12):1010428320977124. PubMed ID: 33256542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis.
    Yoshida T; Ogata H; Kamio M; Joo A; Shiraishi H; Tokunaga Y; Sata M; Nagai H; Yoshimura A
    J Exp Med; 2004 Jun; 199(12):1701-7. PubMed ID: 15197228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of cytokine signaling 1, a newly proposed tumor suppressor gene associated with hepatocellular carcinoma.
    Ohkawa K
    J Gastroenterol; 2004 Jun; 39(6):598-600. PubMed ID: 15235884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.